ACC’s Vascular Disease Member Section and Leadership Council is the home for vascular disease specialists within the ACC, advocating for and advancing the priorities of the community.
Welcome
The Vascular Disease Member Section and Leadership Council works in tandem with College leadership to recommend and provide insight into programs and initiatives relevant to vascular disease professionals. Explore these pages to find out how we do it and who we are.
Become a Member — Join Now.
Serve as a voice for the vascular disease community and become a part of the Section today. To join, call ACC Member Care at (800) 253-4636, ext. 5603 or check the box on your dues statement each Fall.
Member Benefits
The Vascular Disease Member Section provides its participants with opportunities to make a difference in vascular disease and:
- Network with colleagues
- Develop leadership skills
- Advance your career
- Strengthen your skills
- Expand upon your interests within the specialty
Message From the Chair
Welcome to the ACC Vascular Disease Member Section! The Vascular Disease Section is your home for the latest news and developments in the diagnosis, management, and prevention of vascular disease, including arterial, venous, and lymphatic disorders. Read more >>>
Continue connecting with your community on Member Hub!
Ask questions, get feedback and collaborate with colleagues in your private Vascular Disease Section group.
Get Started!
Section News
June 14, 2022
Learn to identify signs and symptoms of Peripheral Artery Disease (PAD) and develop a treatment plan including guideline-directed medical therapy with the Peripheral Artery Disease: Optimizing Treatment Strategies online course
June 14, 2022
Join the ACC Vascular Disease Section & Society for Vascular Medicine for two upcoming webinars on vascular hot topics!
May 31, 2022
Educational Opportunities
The Practical Management of VTE: Simplifying Anticoagulation Strategies online course will guide you in selecting the best anticoagulant treatment strategies for management of VTE and determining the optimal evidence-based therapy.
View More Section News »